Project IMPACT Immunizations (IMProving America's Communities Together)
- Conditions
- Influenza
- Interventions
- Biological: Vaccine administration by a pharmacistBehavioral: Unmet vaccination needs identified and metBehavioral: Vaccination forecast review and patient education
- Registration Number
- NCT02584036
- Lead Sponsor
- American Pharmacists Association Foundation
- Brief Summary
The primary objective of this study is to evaluate how implementing an innovative care model that provides the pharmacist access to a patient's vaccine history at the point-of-care impacts the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations.
- Detailed Description
This is a multi-site, observational study investigating the impact of implementing an innovative care model on the pharmacist's ability to identify unmet vaccination needs and increase vaccination rates for routinely recommended adult vaccinations. The innovative care model enables the pharmacist to utilize a bi-directional IIS to assess patients' vaccination histories, identify unmet vaccination needs, and document the care provided. Data will be collected in the bi-directional IIS. Aggregate de-identified data will be reported to the researchers at the midpoint and conclusion of the study. The project duration has been established to allow sufficient time for each pharmacy to implement the innovative care model and monitor each pharmacy for a 6-month study period. The American Pharmacists Association (APhA) Foundation has an a priori intent to publish the project results.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1080
- Individuals eligible to be enrolled in the study include any person at least 18 years of age receiving an influenza vaccination from a participating pharmacy site.
- n/a
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Receiving Influenza Vaccine Vaccine administration by a pharmacist Patients who receive an influenza vaccine at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met. Receiving Influenza Vaccine Unmet vaccination needs identified and met Patients who receive an influenza vaccine at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met. Receiving Influenza Vaccine Vaccination forecast review and patient education Patients who receive an influenza vaccine at a participating pharmacy site will be eligible to: a) receive a vaccination forecast review, b) be evaluated for unmet vaccination needs, c) receive patient education, and d) have vaccination needs met.
- Primary Outcome Measures
Name Time Method Number of times the pharmacist reviewed the vaccination forecast and educated the patient on his/her vaccine needs through study completion, an average of 6 months Number and types of vaccines administered Change from baseline rates at 6 months Number of unmet vaccination needs identified and met through study completion, an average of 6 months
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (8)
Tieton Village Drug
🇺🇸Yakima, Washington, United States
Lopez Island Pharmacy
🇺🇸Lopez Island, Washington, United States
Quality Food Centers #851
🇺🇸Edmonds, Washington, United States
Quality Food Centers #101
🇺🇸Belfair, Washington, United States
Kirk's Pharmacy
🇺🇸Eatonville, Washington, United States
Cheney-Owl Pharmacy
🇺🇸Cheney, Washington, United States
Kelley-Ross Pharmacy
🇺🇸Seattle, Washington, United States
ReliantRx
🇺🇸Spokane, Washington, United States